Editorial
Working-group output, perspectives on research-administration standards, news from the CASRAI federation, and substantive long-form on the open-research vocabulary.
Carnegie Mellon’s Swartz Center for Entrepreneurship launched a Deep Tech Venture-Ready Program in April 2026 backed by $240M in soft-circled capital from 30 VC and corporate partners — a distinct model from a university venture fund, worth understanding precisely because the capital is prospective, not committed.
FDA’s July 2026 Unified Agenda lists a dozen new proposed rules on clinical trials, Phase 1 IND, DTC ads, and CRL disclosure beyond the IND pilot.
HHS OIG is asking whether the Anti-Kickback Statute needs a new safe harbor for paying clinical trial participants. Comments on the RFI are due August 24, 2026.
Advances in Psychology has paid $100/review since 2022; NIH may reward journals that pay reviewers ~$50/hr and publish their comments.
A 2026 Scientometrics analysis of 248 CoARA action plans finds aspirational ‘values’ language far outweighs concrete operational commitments to open science.
DORA, FORCE11, CoARA and ALLEA convened funders, publishers and universities in Singapore to compare Asia-Pacific approaches to research-assessment reform.
Chile’s ANID is extending its 2022 Open Access Policy across every instrument it funds in 2026, backed by a new EspacioCiencia repository service and renewed InES Ciencia Abierta capacity funding. Here’s what the mandate actually requires.
In May 2026, DORA, the Global Research Council’s Responsible Research Assessment Working Group, and Science Europe jointly published a practical implementation guide for research funding organizations moving toward responsible research assessment — the first RRA resource written specifically for funders rather than institutions.
The UPC’s Patent Mediation and Arbitration Centre opened in phases from May 12, 2026 — what it means for university patent-licensing and enforcement strategy.
FDA shipped Elsa 4.0 and the HALO data platform in May 2026 — an internal AI upgrade, not a sponsor-facing one. Here is what changed and what did not.
EMA’s draft guidance on running clinical trials during public health emergencies closed for comment April 30, 2026. Finalisation is still pending.
FDA’s April 2026 RFI sought input on an AI-enabled early-phase trials pilot. Comment window closed June 29, 2026 — here’s what it covered.
A BMJ study used a BERT classifier to screen 2.6 million cancer papers, flagging 9.9% as suspected paper-mill output — a scale manual review cannot match.
The European Commission’s June 2026 study analysed 263 ARRA action plans, finding reform engagement broad and growing but uneven across Europe.
Clarivate paused Web of Science indexing for six IJS Publishing Group journals after mandatory reporting-guideline citations inflated their impact factor.
Nature reports China’s multiple-corresponding-author rate hit ~30% by 2020, up from 21.6% in 2016 — tied to evaluation incentives, not byline convention.
A 2026 Journal of Informetrics study uses CRediT data to measure contribution among co-corresponding authors, finding it rises with byline position.
A January 2026 Royal Society Open Science paper models why contribution-insensitive authorship norms (alphabetical, senior-last) evolve via a ‘Red King’ dynamic — and shows they measurably discourage collaboration compared to contribution-sensitive norms.
EO 14332 (Aug. 7, 2025) directs new termination-for-convenience rights, F&A-cost preferences, and DEI-linked terms for discretionary federal grants.
The Royal Academy of Engineering’s 2026 Spotlight on Spinouts report finds UK universities’ average spinout equity stake has fallen to 16%, a decade low, down from 22% the year before — with life sciences averaging 20% and hardware 14%, both within the Independent Review’s recommended 10-25% band.
NIH plans to widen All of Us pediatric enrollment to ages 0-12 in 2026, even as the program absorbs a steep funding drop from FY2023 levels.
FDA eased CMC expectations for cell and gene therapy BLAs on Jan 11, 2026 — finalized in May, extended to genome editing in June.
New Zealand has cancelled PBRF quality evaluation for good; Australia’s ERA replacement remains undesigned three years after ERA ended in 2023.
NSF’s own FY2027 budget request confirms its Office of Inspector General has cut roughly 22 positions (24%) since January 2025, lost its investigative-scientist staff, and now refers research-misconduct allegations to grantee institutions instead of investigating them directly — following the departures of Inspector General Allison Lerner and Deputy IG Ken Chason.
A Lancet Correspondence auditing 2.5 million PubMed Central papers found fabricated citations rose from 1-in-2,828 papers in 2023 to 1-in-277 in early 2026 — and over 98% of flagged papers have seen no publisher correction.
RDA’s 27th Plenary meets in London Oct 6-8, 2026, hosted by UKRI — piloting a new cadence pairing yearly virtual and in-person meetings.
The EU’s proposed Biotech Act (Commission proposal adopted 16 December 2025, not yet enacted) would revise Clinical Trials Regulation Article 93 to align it with GDPR, naming sponsors and investigators as data controllers and permitting cross-trial data reuse — here is what is actually proposed, what the EDPB-EDPS flagged as unresolved, and what remains to be decided.
NeurIPS 2026 has made the Machine Learning Reproducibility Challenge an official track, with TMLR-accepted papers presented in Sydney this December.
OpenAlex’s January 2026 roadmap: the Walden rewrite to Databricks is done, Awards is now a first-class entity, and credit-based API pricing is rolling out.
Kenya launched a 2026-2036 research-financing masterplan and the Grand Challenges Kenya fund to close its R&D spending gap and cut aid reliance.
An FDA warning letter dated July 10, 2026, cites a bioequivalence-trial investigator tied to an Alembic Pharmaceuticals facility for obtaining informed consent after study procedures had already begun. Here is what the letter actually says, and what unverified secondary claims about it do not hold up.
RoRI’s PEER REVIEW project wraps up with a June 2026 report: peer review has hit a breaking point, and needs a layered, funder-led reform blueprint.
As of Feb. 2026, OpenAlex requires an API key for all production API use and bills most calls on usage, with a daily free allowance per key.
A June 2026 House Science subcommittee hearing examined FCA grant-fraud enforcement, spotlighting undisclosed foreign affiliations as a growing DOJ target.
On Feb 27, 2026, the EU Commission issued its first Research Security Monitor plus a Council Recommendation on science diplomacy, adopted May 29, 2026.
ROR’s March 2026 recap of its Annual Community Meeting reports that nearly 20% of the 8,000+ organization records added in 2025 are in East Asia, and confirms ‘single search’ becomes ROR’s default affiliation-matching strategy in 2026. A separate, unrelated ROR post the same month marks the registry’s 7th anniversary with a POSI commitment update.
ARC’s 5-goal PID Action Plan — DOIs on grants, ROR on institutions, ORCID on personnel, plus a FAIR data policy — is due complete by end of 2026.
DMPTool is rebuilding on a modern API architecture for machine-actionable DMPs. Its summer 2026 target has slipped to late 2026 after NIH/NSF changes.
FDA’s Dec. 2025 guidance pushes sponsors to justify restrictive eligibility criteria, distinct from and broader than the FDORA diversity action plan mandate.
ARPA-H’s Advancing Clinical Trial Readiness (ACTR) initiative aims to put a clinical trial site within 30 minutes of 90% of eligible Americans. Here’s what the program covers, its three funding focus areas, and where it stands.
DORA published a Practical Guide to Responsible Research Assessment for funders, with GRC and Science Europe, launched via regional events 13-14 May 2026.
Northwestern paid $2.3M under HHS-OIG’s Civil Monetary Penalties Law after self-disclosing a Feinberg researcher’s falsified NIH grant data.
Texas HB 127 (not SB 1565) sets an August 2026 research-security certification deadline for Texas public university boards.
ORCID has published ORCID 2030: Advancing the Future of Research, its strategic plan for 2026-2029, built around five themes: empowering researchers, connecting research information, broadening its community, advancing trust and integrity, and strengthening its own resiliency. Here’s what the plan actually says and what it signals for research administrators.
Software Heritage marked 10 years in Jan 2026, gained UNESCO/DPGA digital-public-good status, and struck a Sovereign Tech Agency archival partnership.
NIH has folded replication and reproducibility into its 2026 Gold Standard Science agenda: a new agency-wide Highlighted Topic, continued Common Fund replication funding, and an RFI on rewarding rigor in review. Here’s what’s actually new versus the existing 2016 rigor policy, and what it means for grants and data management offices supporting NIH-funded investigators.
EACL 2026’s call for papers confirms that submissions missing a dedicated Limitations section are desk rejected without review — a completeness check, not a quality judgment, that flows from ACL Rolling Review’s shared policy across the ACL, EMNLP, and NAACL submission pipeline.
As of January 2026, Quebec’s FRQ requires the narrative CV-FRQ for all its competitions, replacing the Canadian Common CV across all FRQ-funded programs.
Clarivate’s 2026 Journal Citation Reports gave 521 journals a Journal Impact Factor for the first time, from 47 countries/regions, with 58% based outside the US and Western Europe — part of a multi-year geographic-diversification trend research offices should track.
NIH’s RFI NOT-OD-26-086 proposes capping how many Research Project Grants one PI can hold at once. Comments closed August 3, 2026; no final policy yet.
In April 2025, NEH terminated more than 1,400 grants worth over $100 million; a federal judge has since ruled the mass termination unconstitutional. Starting June 30, 2026, NEH began asking each affected recipient to formally reconfirm, via a Reinstatement Assurances Form, that they still want the award back.
GAO: 5 top research-funding agencies havent assessed whether security screening risks discriminating against Chinese and Asian-descent scientists.
The House-passed DETERRENT Act would cut the Section 117 foreign-gift threshold to $50,000. A 26-group coalition pushed the stalled Senate bill in May 2026.
Cornell University Library relaunched eCommons on DSpace-CRIS, hosted by 4Science on AWS, on May 18, 2026 — a real institutional CRIS-migration case study.
AfriGen-D, a pan-African human genomics data hub, launched May 7, 2026, led by UCT, Institut Pasteur de Tunis, and University of Mauritius.
Duke University Libraries has completed migrating its Research Data Repository from the Hyrax/Samvera stack to TIND RDM, a platform built by CERN spinoff TIND, adding a submission dashboard, dataset versioning with new DOIs per version, file preview, and expanded ORCID/ROR support while preserving existing DOI resolution.
BIOSECURE Act became law Dec 18, 2025 (NDAA Sec. 851), restricting federal contracts and grants tied to designated biotechnology companies of concern.
The EU’s February 2026 Research Security Monitor and forthcoming Centre of Expertise add EU-wide policy coordination beyond Horizon Europe grant screening.
A Nov. 2025 OpenReview bug exposed ICLR 2026 reviewer identities, enabling bribery and harassment amid separate reports that 21% of reviews were AI-generated.
A February 2026 study surveyed 375 North American accounting researchers on 44 debatable research and authorship practices, mapping where field norms diverge.
A 2026 accounting change requires NIH to obligate a multi-year grant’s full cost up front instead of year-by-year, shrinking how many new awards its budget can fund. Reported figures show R01-equivalent awards down roughly 24% year-over-year, overall success rates falling toward the high-teens (lowest in decades per some trackers), and NCI applicant odds reportedly falling from about 1-in-10 to about 1-in-25.
Argentina’s INPI Resolution 38/2026 simplifies technology transfer agreement registration under Law 22,426, easing tax-relevant filings for global licensors.
Nigeria’s Federal Executive Council approved the National Intellectual Property Policy and Strategy (NIPPS) on November 6, 2025, and the government launched implementation on December 17, 2025. Here is what the framework actually changes for university IP commercialization and technology transfer offices.
From 1 April 2026, UKRI no longer accepts uninvited resubmissions of rejected proposals. Here is what changed and how it reshapes grant-writing strategy.
OpenAlex now ingests DataCite’s funder and grant metadata daily, part of a $3.6M Wellcome grant to build open funding infrastructure.
EO 14411 (June 22, 2026) tightens research-security and export-control coordination for quantum research. What it means for QIST funding and tech transfer.
In June 2026, Cambia sold The Lens to a new Australian non-profit under SPIE. Here’s what changes, and what does not, for Lens.org researchers.
ResearchGate retired the opaque RG Score around 2022 for the Research Interest (RI) Score, a formula weighting citations, recommendations, and reads.
Korean universities lead on paper counts but lag on citation impact and R&D return. NRF data, a Springer Nature forum, and researcher surveys are fueling a live debate over moving past publication-count evaluation.
Crossref’s 2026 public data file shows ROR IDs up 250% and grant-identifier links reaching 50,000 records, alongside its first Latin America Metadata Sprint.
Danish researcher Poul Thorsen was extradited from Germany after 15 years as a fugitive and arraigned on 22 federal wire fraud/money laundering counts.
The Supreme Court declined to hear Thaler v. Perlmutter (March 2026). What the human-authorship rule now means for CRediT, ICMJE, and AI disclosure practice.
AGU’s 2024 authorship update asks researchers to name local collaborators as co-authors, not just acknowledgments. Here is what changed and why it matters.
CAPES and Springer Nature have signed a three-year transformative agreement (Jan 2026-Dec 2028) giving authors at 400+ Brazilian institutions APC-free open-access publishing in 1,730+ hybrid journals and reading access to 1,770+ titles.
MALMAD, Israel’s national open-access consortium renewed its deal with The Company of Biologists through 2028, part of a staggered publisher portfolio.
Wolters Kluwer retracted nine transplant papers in July 2026 over unresolved organ-sourcing ethics tied to a 2019 scoping review.
Denmark’s NORA research portal moved from DTU to Statistics Denmark in Jan. 2026, ahead of a reported consolidated, open-architecture database later in 2026.
ASTM’s Journal of Testing and Evaluation retracted ~166 papers after a vendor found compromised peer review in guest-edited special issues.
A 2026 Accountability in Research study tracks faculty-student authorship-ethics views and tests whether training plus policy closes the gap.
In May 2026, arXiv began enforcing a one-year submission ban for authors whose papers show unchecked AI-generated content — hallucinated references or leftover chatbot text. Here’s what triggers it, how it’s enforced, and what it means for author accountability.
Dana-Farber paid $15M in Dec. 2025 to settle a DOJ False Claims Act suit over manipulated images in NIH-funded papers, and what it means for grant compliance.
The PREVAIL Act would tighten PTAB patent-challenge rules, but 2026 progress has stalled in committee — what it means for university TTOs.
Poland is overhauling how universities are scored, replacing rigid publication-point quotas with a two-pillar model adding qualitative criteria.
ERC restructured its 2026 Scientific Proposal: Part I (5pp, concept) and Part II (7pp, implementation) replace B1/B2; feasibility now assessed in Step 2.
HHMI (2026) and Gates Foundation (2025) both push preprints, but neither strictly requires posting before submission — what each policy actually says.
In April 2026 the OECD published a policy brief, Reforming Research Assessment for Better Science, finding that assessment still relies on narrow metrics that undervalue collaboration, openness, and societal impact, and recommending governments treat reform as a national science-policy priority.
CAUL reached in-principle 2026 open-access deals with Taylor & Francis, Springer Nature, Wiley, and, after stalled November talks, Elsevier.
CRKN, Canada’s national library consortium, is negotiating 2026 licenses with Elsevier, Sage, Springer Nature, T&F, and Wiley on cost and transparency.
Agents4Science 2025, organized by researchers at Stanford and Together AI, ran as a one-day virtual conference on October 22, 2025 with an unusual submission rule: an AI system had to be the paper’s primary author, generating the hypotheses, running the experiments, and writing the manuscript, with a human listed as a supervising co-author. It is one of the most concrete tests to date of how authorship credit and disclosure norms hold up when the ‘researcher’ doing the work is an AI agent.
The SAFE Research Act would have cut federal funding over ‘hostile foreign entity’ ties. University pushback got it struck from the FY2026 NDAA.
How researchers access LSST data: Rubin Science Platform accounts, data-rights eligibility, and Data Preview 2’s July 2026 rollout and two-year embargo.
A 2026 bibliometric analysis of roughly 480,000 PubMed and PMC records (2010-2024) finds equal-contribution tags climbing from a median of about 19% of articles in 2015 to over 30% in 2024, with China driving most of the growth.
Sweden’s Bibsam Consortium, coordinated by the National Library of Sweden, has adopted an action plan to stop signing hybrid read-and-publish agreements from 2026 onward, negotiating only with fully open-access publishers instead — following a 2023 SUHF recommendation on moving beyond transformative agreements.
HHS’s Simpler.Grants.gov initiative has shipped a new default search, account and submission-tracking tools, and a public API through 2025-2026 — but full application submission and a legacy Grants.gov retirement date are not yet confirmed. Here’s what’s actually changed for applicants.
A Walsh Medical Media journal published a commentary under a University at Buffalo researcher’s name without his knowledge, then demanded EUR400, later EUR499, before it would remove the false byline — and ultimately just swapped in a different, unverifiable author name instead. Retraction Watch’s March 2026 report ties the publisher to OMICS International, fined over $50 million by the FTC in 2019.
Switzerland had no national Springer Nature contract from Jan-June 2026. A new 2026-2029 Read & Publish deal, signed 10 June 2026, adds Gold OA.
CERN will operate the next phase of Open Research Europe from autumn 2026, backed by roughly €17 million in funding from 16 agencies across 11 European countries. Authorship eligibility expands beyond EC-funded researchers, but the diamond OA model — free to publish, open post-publication peer review — stays the same.
ROR retired version 1 of its API and metadata schema in December 2025. Here is the actual timeline, what changed in schema v2, and what to check if your institution has any ROR-consuming integration.
CRediT taxonomy translations now cover 35+ languages via a community project, not an official NISO release — what it means for non-English journals.
Zochi (Intology) and Sakana’s AI Scientist each passed real peer review in 2025 — one at ACL, one at an ICLR workshop. What it means for authorship.
Between late 2025 and early 2026, arXiv tightened endorsement (no more institutional-email-only qualification), required full English-language versions of every submission, and began requiring documented prior peer review for CS literature surveys and position papers after a flood of AI-generated submissions.
Gates Foundation, Novo Nordisk Foundation, and Wellcome launched Gr-ADI in January 2026 with $60 million for 18 antibiotic-discovery projects in 17 countries — the first major investment inside their broader $300 million global-health R&D partnership, and a notable model for joint-funder consortium grant terms.
University of Melbourne has opened a formal probe into education researcher John Hattie over alleged plagiarism and fabricated AI-style citations.
Frontiers retracted 122 articles after uncovering a ~35-author peer-review collusion network with undisclosed COI and citation manipulation.
Commerce cut, then restored, foreign access to Anthropic’s Fable 5/Mythos 5 over a jailbreak claim — what it means for research-security compliance.
UKRN’s STAR Study (Working Paper 12, July 2026) finds UK universities have built open-data policy and repository infrastructure since 2016, but adoption remains compliance-driven and has stalled — here’s what it found and recommends.
A rejected economics paper was resold on Telegram as authorship slots for as little as $55, published, then retracted — a documented paper-mill tactic.
The Netherlands fully revised its National Knowledge Security Guideline on 9 July 2026, updating the threat assessment and adding a risk-indicator appendix.
Norway retired Cristin during 2025 in favor of NVA (Nasjonalt vitenarkiv, the Norwegian Research Information Repository), a single national system operated by Sikt that also absorbed 60-plus institutional repositories, including BORA. Here is what changed for researchers and administrators.
The EU Council reached a partial position on FP10 (2028-2034) on 26 June 2026: EUR175bn proposed, four pillars. Here is what is agreed vs still open.
Peer Review Week 2026 runs Sept 14–18 under the theme “Peer Review Capacity: Volume, Speed, and Quality.” What it means for reviewers and publishers.
Bibliometric data show single-author systematic reviews climbing steadily since 2000 — including inside Cochrane’s own database — despite guidance calling for independent dual-reviewer screening.
2025 bibliometric studies show women’s senior- and corresponding-authorship share still lags first-authorship gains, with implications for research policy.
In January 2025, CNR convened Italy’s 1st National Congress on Research Integrity in Rome, producing the Declaration of Rome. CASRAI covers the CNR committee behind it, the Congress, and the national oversight gap the Declaration itself names — including the proposed National Observatory of Research Integrity.
Senate Judiciary July 14, 2026 hearing on PERA (S.1546) weighed patent eligibility for diagnostics and AI — key stakes for university tech transfer.
Elsevier expanded Check Integrity to nearly 2,000 journals in March 2026, flagging unauthorized authorship changes and editorial conflicts of interest.
Sheffield, Lancaster, Surrey, Essex, Kent, Sussex, and York declined Elsevier’s 2026 deal after Jisc’s national negotiation cycle, citing unsustainable costs.
MOST Order No. 24 lists 68 categories of research misconduct across six actor types, part of China’s push to hold institutions accountable.
The EDPB’s draft Guidelines 1/2026, published 15 April 2026, set out a six-factor test for “scientific research” under GDPR and detail Article 89 safeguards, legal bases, and a restrictive line on data-subject-right derogations. Consultation closed 25 June 2026; the text is not yet final.
euroCRIS’s 17th CRIS Conference (CRIS2026) drew 112 attendees to the University of the Azores in May 2026, covering open science, interoperability, and AI. A recap of what happened and why it matters for CRIS managers.
MIIT’s revised technology contract registration rules, effective March 1 2026, tie VAT/CIT tax breaks to registered transfer, licensing, and R&D contracts.
China’s Ministry of Science and Technology has ordered universities to investigate retracted papers for misconduct and warned of penalties for looking away.
PTAB again ruled Broad/MIT/Harvard, not UC Berkeley’s CVC, invented eukaryotic CRISPR-Cas9 first — reaffirming priority on Federal Circuit remand.
Canada’s PRCR ran a Feb 17-Apr 17, 2026 consultation proposing to remove any statute of limitations on research misconduct allegations, alongside new rules on anonymous complaints, post-departure accountability, and retaliatory-allegation protections. The comment period has closed; no revised Framework has been published yet.
Commerce opened a Bayh-Dole march-in proceeding against Harvard’s patents in Aug. 2025 — the first agency-initiated test of march-in rights.
FDA’s Commissioner’s National Priority Voucher (CNPV) pilot promises a one-to-two-month review for drugs meeting national health priorities. Here’s how it differs from statutory Priority Review Vouchers, who has received one, and where the program stands as of FDA’s 2026 public hearing.
Crossref has published its first position paper, arguing that national and international PID policy focused narrowly on identifiers misses what actually makes research infrastructure work: open linked metadata and sustainably governed organisations. The paper offers five recommendations for policymakers and draws worked examples from the UK, Portugal, Canada and South Africa.
Since October 1, 2025, applicants for commercial patent licenses on NIH-owned (intramural) inventions must submit an access plan addressing affordability, availability, acceptability, and sustainability. It does not apply to university-owned inventions from NIH-funded (extramural) research — here’s what tech-transfer offices need to know about scope, requirements, and the effective date.
Health Canada’s draft Clinical Trials Regulations and its April 2026 ICH E6(R3) adoption mark Canada’s biggest trial-oversight overhaul in decades.
FDA’s June 22, 2026 revised draft guidance clarifies when a single adequate and well-controlled trial plus confirmatory evidence can satisfy the substantial-evidence-of-effectiveness standard for drug and biologic approval, narrowing the traditional two-trial default. Comments are open through September 22, 2026.
FDA published draft guidance Jan. 12, 2026 setting expectations for Bayesian primary-analysis designs in drug/biologic trials. Comments closed March 13, 2026.
A second 2026 wave: editors left journals at Springer Nature, Wiley, and Taylor & Francis over volume quotas, publisher control, and open-access disputes.
CMS and FDA launched RAPID on April 23, 2026, targeting Medicare coverage within 60-90 days of FDA authorization for breakthrough devices, pausing TCET for new candidates.
The 3rd Global Summit on Diamond Open Access (Bengaluru, Feb 2026) produced a six-pillar global roadmap for OA policy, funding, and evaluation reform.
A D.D.C. court granted summary judgment for HHS on Dec. 12, 2025, upholding ORI’s misconduct findings and 3-year debarment of researcher Ivana Frech.
Elsevier, Springer Nature, and Taylor & Francis journals saw mass editor resignations in 2026 over governance, an APC mandate, and referee load.
FDA’s final guidance sets trial-design rules for psychedelic drug studies, addressing functional unblinding and abuse-potential testing.
NSF restarted SBIR/STTR for FY26 with $250M, a new $30M Strategic Breakthrough tier, a $40M instrumentation pilot, and a July 27, 2026 deadline.
On July 14, 2026, FDA finalized guidances on generic topical corticosteroid bioequivalence testing and formal FDA meetings for OTC monograph drug sponsors.
University of Zurich cleared neuropathologist Adriano Aguzzi of misconduct, but flagged 7 of 36 studies for image errors he must now retract or correct.
A new dataset, BuyTheBy, quantifies for the first time what paper mills actually charge for authorship: 18,710 ads, prices from roughly $56 to $5,631 for first-author slots, and just 5 of 53 matched published papers retracted so far.
COPE’s new Code of Conduct for members is live, replacing the retired 2024 Core Practices, with a 12-month transition before adherence is mandatory.
South Korea’s National Research Foundation found no research misconduct in Changwon National University president Park Min-won’s papers, closing a three-year plagiarism and duplicate-publication review.
ICML 2026 used hidden PDF watermarks to catch 506 reviewers using AI, desk-rejecting 497 papers tied to 398 of them amid a record 23,918 submissions.
China’s National Health Commission disclosed 28 sanctioned misconduct cases spanning data fabrication, paper trading, and guest authorship.
HORIZON-ZEN+, a CERN-coordinated EU project (2025-2027), adds AI-assisted curation and discovery tools to Zenodo’s EU Open Research Repository.
ICML 2026 study: AI peer-review scores can be gamed by cosmetic ‘paper laundering’ rewrites, a risk authors warn could disadvantage novel work.
UHERO withdrew a Hawaii electricity-policy report in July 2026 after its author found an AI assistant had inverted a key solar-pricing trend from a Berkeley Lab dataset, unverified before publication — a live case study in AI-disclosure and verification gaps.
The European Commission convened 28 EOSC Nodes and 34 Horizon Europe EOSC projects in Brussels, July 7-9, 2026, marking 14 new Nodes and ~€500M in investment.
OMB’s proposed grants rewrite would give political appointees final sign-off and recast peer review as advisory. Comments closed at 340,000+.
NIH is centralizing peer review of fellowship (F), career development (K), and training (T) applications, giving more weight to candidate potential and training goals — part of its broader Unified NIH Funding Strategy.
CMS’s CY2027 fee schedule proposal narrows, not bans, third-party RPM/RTM billing. Here is the real mechanism, the OIG data behind it, and what it means for clinical trial billing compliance.
OSTP’s July 2026 report and FY2028 memo direct agencies to fund researchers over institutions and diversify grants beyond peer review.
Wiley is investigating a peer reviewer accused of demanding payment to approve a manuscript at journal Security and Privacy.
AHRQ has issued near-identical “non-award” letters ending continuation funding for dozens of active grants, citing portfolio prioritization. HHS says these are not terminations; grantees and advocacy groups disagree, a distinction with real consequences for appeal rights and sponsored-programs planning.
UKCORI co-lead Miles Padgett told the UK Reproducibility Network conference the committee has no operations planned beyond 2027, and sketched a scenario for a new centralised UK research-integrity body — not yet a confirmed policy.
Five researchers, including Harvard geneticist George Church, were moved off a Nature Methods byline into acknowledgements amid U.S. scrutiny of China ties.
A Tufts historian’s award-winning book failed an external peer review. The AHA rescinded her prize; she’s no longer at Tufts and disputes the findings.
ERC Work Programme 2027 (adopted 20 July 2026): wider Starting/Consolidator eligibility windows, one-proposal limit, Synergy call moved to February.
Wellcome revises grant eligibility from 1 July 2026 and restricts lead-applicant hosts to the UK and LMICs in Africa, South and SE Asia from 29 October 2026.
Springer Nature reports nearly 40% of citations to China’s 2022 gold OA articles now come from outside China, while a separate June 2026 announcement puts its EU open-access agreement coverage at 74% of member states, including renewed Czechia, Greece, and Finland deals.
How NorthStrive Defense Tech’s exclusive FSU drone-payload license moved from option (Apr 2026) to term sheet (Jun) to signed license (Jul 2026).
ALZAI Health took an exclusive, worldwide license to AI liver-risk tech from Yeda (Weizmann) and MOR (Clalit) — a royalty deal, not equity.
Rutgers University is investigating whether payments its own units made to Dean Jacqueline Mattis’s writing-retreat company, Easton’s Nook, violate New Jersey conflict-of-interest law. Reported totals range $145K-$155K over about nine years; the probe is ongoing.
Sage retracted 8 papers by ex-editor Yannick Griep for self-reviewed peer review; Radboud separately confirmed data fabrication.
ORCID and China’s CSTR Identification Platform signed an MOU on July 16, 2026 to pursue interoperability between their persistent identifier systems. No technical implementation details have been published yet; here’s what the agreement covers and why CRIS and research-administration teams working with Chinese research partners should watch it.
A new Learned Publishing study finds 83% of high-impact journals have explicit AI peer-review policies, versus 75% of mid-tier titles.
On 16 July 2026, Springer Nature launched Nature Books, a new imprint that lets authors publish long-form work under the Nature brand for the first time. It sits alongside Springer and Palgrave Macmillan within Springer Nature’s roughly 14,500-title-a-year book business, with proposals guided by an editorial board of in-house Nature Portfolio editors before commissioning, peer review, and production move to Springer Nature’s existing books teams.
A 2.7-million-preprint IEEE S&P 2026 study found 88% of arXiv submissions leak hidden source-file data: passwords, API keys, GPS coordinates.
Nobel laureate Thomas Südhof told Lindau 2026 that publishing is unregulated, dismissed COPE as self-serving, and urged a government “FDA for journals.”
A March 2026 ORI finding against former Mount Sinai postdoc Chen-Yeh “George” Ke — for falsified images in a draft manuscript and NIH progress reports — prompted independent image-forensics sleuthing of his broader publication record. That work surfaced an unrelated duplicated image in a 2019 Science Signaling paper, which the journal retracted in July 2026 after finding further discrepancies.
FDA reopened comment on its master protocol draft guidance in June 2026, adding new basket-trial recommendations. Comments are open through August 24, 2026.
ORI’s final rule revising 42 CFR Part 93 took effect Jan 1, 2025 and applies to allegations received on or after Jan 1, 2026. Here’s exactly what changed.
NSF 26-022 bars NSF-funded collaboration with entities on seven federal restricted-party lists, starting FY2027. Here’s what it does and doesn’t cover.
In 2026, the University of Alberta, University of Delaware, and University of British Columbia each ended a major bundled journal subscription — with Springer Nature, Wiley, and Sage respectively — citing publisher price increases that have outpaced flat collections budgets. Here’s what each library actually announced, and what changed for researchers.
On July 1, 2026, arXiv left Cornell University’s umbrella to become arXiv, Inc., an independent 501(c)(3) nonprofit. Cornell and the Simons Foundation are founding Members with board seats on a 12-member board; a $10M Simons/Schmidt Sciences gift funds cloud migration. The arxiv.org URL, free access, staff, and moderation process are unchanged.
OMB’s May 2026 proposed rule would bar federal grant funds from collaboration with “covered foreign countries.” Here’s what the rule’s text actually says, why the widely-cited “17 countries” figure isn’t a real OMB list, and how this differs from the CHIPS Act’s countries-of-concern list.
BIS’s 2026 settlements, led by a record $252.5M Applied Materials case, reveal what triggers export-control violations for research institutions.
COGR’s June 2026 meeting included a GAO briefing flagging research security as a top oversight area. What’s confirmed, and what it means for research admins.
GAO-26-107738 (May 2026) found 2 of 9 agencies lacked a public-access policy, reuse-rights gaps at NSF/USDA, and costs it warns could reach $1B/year.
Executive Order 14292 (May 2025) paused federal funding for dangerous gain-of-function research and set OSTP deadlines for oversight rules, now overdue.
MA3 (Modernizing Academic Appointment & Advancement) is a US-specific research-assessment reform initiative, distinct from DORA and CoARA: it funds a defined cohort of universities to actually rebuild hiring, review, promotion, and tenure processes rather than sign a statement of principle. Here is what it is, who runs it, and where it stands.
A March 2026 law-firm alert warns the fundamental research exclusion is quietly narrowing for universities. No BIS or Federal Register rule change was found to confirm that framing — here’s what’s actually enacted (NSPM-33, Section 117, the BIOSECURE Act) versus what’s still just a warning.
FDA’s proposed Expedited IND Pilot Program would speed first-in-human trials via Qualified Research Institutions; comments now due Aug. 24, 2026.
NIH Notice NOT-OD-26-064 ends Continuous Submission after August 10, 2026, and narrows late-application eligibility for all applicants NIH-wide.
ARC’s updated Open Access Policy took effect 1 July 2026: immediate OA for articles, a 12-month window for books, and new Indigenous research provisions.
NIH’s 15% indirect-cost cap is dead: the First Circuit upheld the injunction against it in January 2026, and DOJ let its Supreme Court appeal deadline lapse in April 2026 without filing. Congress has separately blocked equivalent caps at NIH, DOE, and NSF through appropriations riders. The remaining risk isn’t litigation — it’s the annual budget-request cycle.
FDA has initiated two proof-of-concept real-time clinical trials and opened an RFI on a broader RTCT pilot program. Final selection criteria are expected in July 2026, with pilot selections completed in August 2026.
NSF named 12 new Regional Innovation Engines across 20 states on July 14, 2026, each eligible for up to $160M over 10 years.
OMB’s proposed rewrite of the Uniform Guidance (2 CFR 200) closed for comment July 13, 2026. What it would change, and its status toward an Oct. 1 target.
The ARC’s updated Generative AI policy took effect 28 April 2026, setting rules for applicants, assessors, and research offices.
US university budget cuts and layoffs have continued into summer 2026, with new rounds at Johns Hopkins, the University of Minnesota, The New School, and others. Some are explicitly tied to NIH, NSF, and USAID funding disruption; others are driven mainly by enrollment or state-funding pressure. Here’s what’s documented, institution by institution.
CIHR, NSERC, and SSHRC’s revised Tri-Agency Guide on Financial Administration takes effect April 1, 2026. The key change: a new Buy-Canadian purchasing expectation for grant-funded spend, plus a tighter rule on consulting fees paid to grant-team-affiliated entities.
Effective June 1, 2026, NIH requires prior approval before adding a new domestic subaward not in the original approved application.
Hachette, Cengage, Elsevier, and Scott Turow sued Google in SDNY, alleging Gemini trained on Google Books, Play Books, and Scholar without authorization.
NSF’s PAPPG 26-200 supplement (eff. Dec. 8, 2025) revised SBIR pitch rules, funding caps, equipment thresholds, and research-security requirements.
ED’s Feb. 23, 2026 pact with State adds national-security review to Section 117 foreign-gift oversight. Thresholds and deadlines are unchanged.
Retraction Watch’s database has logged over 63,000 retractions. In April 2026 congressional testimony, RW cited a current 0.2% overall retraction rate.
COPE relaunched its paper mills working group in June 2026, citing AI-exploited coordinated misconduct as the driver, with a companion toolkit to its systematic-manipulation guidelines as the group’s first stated deliverable.
NIH triaged applications into discussion tiers to clear its shutdown backlog; a related funding-criteria shift drew reported political-influence concerns.
Federal agencies now require ORCID as a digital persistent identifier; universities are setting their own 2026 linkage deadlines ahead of enforcement.
Wiley will launch eight new journals under its “Advanced” brand by the end of 2026, expanding beyond materials science into oncology, AI, robotics, and chemical engineering. For researchers and research administrators, the practical questions are the ones the launch announcement doesn’t answer: none of the new titles will have a Journal Impact Factor for at least two years, and Wiley has not disclosed open-access status or APCs for any of them.
NIH’s Common Forms leniency period ended May 8, 2026: eRA now blocks SciENcv biosketch/support submissions with unlinked ORCID or eRA Commons.
A new analysis of the Retraction Watch Database (1997-2026) finds Elsevier has the lowest normalized retraction rate and by far the highest reinstatement rate among ten major publishers — with a caveat from the study’s own author about what that actually measures.
STAT’s April 2026 investigation traces BMJ’s retraction of 7 of 8 papers in a guest-edited Journal of Medical Genetics issue, and the pattern behind it.
NIH’s May 2026 notice explains when AI use in funded research crosses into research misconduct, and what enforcement follows.
REF 2029 criteria-setting paused 4 Sept 2025, resumed 10 Dec 2025: CKU/E&I/SPRE weightings, a 5-output cap, and lighter impact rules are now confirmed.
The US Office of Research Integrity’s 2026 case summaries include a 15-year debarment of former Rice University professor Ariel Fernandez for fabricating data across 12 published papers — one of ORI’s longest debarment periods on record. Alongside two other 2026 cases, it shows an active federal misconduct-enforcement pipeline continuing to work through cases under the current, recently revised 42 CFR Part 93 framework.
cOAlition S’s Strategy 2026-2030 widens accepted open-access routes beyond Plan S’s original three, deferring rule changes to a 2026-2027 review.
NSPM-33’s $50M research security program deadline isn’t one fixed July 2026 date — it’s agency-specific. Plus DoD’s Jan. 2026 memo, explained.
The European Commission adopted Horizon Europe’s 2026-2027 Work Programme on 11 December 2025: EUR 14bn, at least 35% for climate, and a new valorisation push.
DHS’s new rule ends open-ended F-1/J-1 admission, capping it at up to 4 years and requiring a separate USCIS extension filing, effective Sept. 15, 2026.
ClinicalTrials.gov is retiring the Classic Protocol Registration and Results System (PRS) in stages through 2026 and 2027, moving every sponsor and registrant onto the Modernized PRS. Here is the confirmed timeline, from the July 2026 cutoff on new records to the Fall 2026 submission deadline, and what to do before each one.
Where Harvard’s federal research funding fight stands in 2026, and why the appeal’s jurisdictional question matters for every funded institution.
Federal judge Rita Lin has repeatedly ordered NSF and NIH to restore suspended UCLA grants via preliminary injunction in an ongoing UC faculty lawsuit — roughly $81M (NSF, Aug 2025) and $500M/500 grants (NIH plus DOD/DOT/HHS, Sept 2025). As of July 2026 the case is still open toward a final ruling, with a hearing set for October 20, 2026. Here is what “restored” by preliminary injunction means operationally for a research office — and why it is not the same as a resolved dispute.
A 2026 status map of Accord implementation: HELP/HECS reform now law, university funding mid-transition, ATEC on its own legislative track.
MDPI’s multi-year Proofig AI deal and ASM’s Imagetwin pilot data show AI image-forensics screening becoming standard in publisher editorial workflows.
The 2022 Nelson Memo required every federal funder, not just NIH, to adopt zero-embargo public access by Dec. 2025 — here’s where agencies stand in 2026.
Congress rejected the White House’s FY2026 proposal to eliminate the Fogarty International Center, funding NIH’s global health research arm at $95 million — flat with FY2025. Here’s the current status.
Wiley disclosed $49M in FY2026 AI licensing revenue ($110M lifetime). Taylor & Francis and Springer Nature show similar deals; small publishers see little.
A Feb. 2026 C&EN investigation found citation cartels inventing fake author identities and misusing APC waivers to sell undetectable citation boosts.
The FY2026 Labor-HHS appropriations report directs HHS to process grant disbursements within 5 business days, with exceptions. What NIH awardees should know.
A PNAS study of 5.2M papers found 70% of journals have AI policies, but only ~0.1% of papers actually disclosed AI use.
ICMJE updated its Recommendations in January 2026, adding a new standalone Section V on AI use and a new Section III.L.2 on authors’ access to trial data, plus revisions to sponsor-agreement, misconduct, trial-registration, and funding-disclosure guidance.
UKRI’s 22 June 2026 FAQ update clarifies Horizon Europe Guarantee compliance and block grants, part of a 2026-2030 Open Access Monitor plan.
NeurIPS 2026 desk-rejected 178 position papers (18.4%) via the Pangram AI detector, no appeal allowed. What is verified, what is disputed, and why it matters.
Congress rejected NIH’s 27-to-8 institute consolidation in FY2026 funding, but administrative restructuring continues. Here’s the current status.
Where 2026 litigation over SEVIS record terminations and visa revocations stands, and what it means for international researchers.
The 2025 H-1B $100,000 fee hits new petitions requiring consular processing, including at universities. Litigation is ongoing — current status inside.
NSF’s indirect cost cap attempt was blocked and Congress has barred new rate changes. Grant terminations tied to DEI/environmental-justice criteria are being litigated on two separate tracks with different outcomes so far, and NSF’s budget remains under pressure. Here is the current, still-moving status as of mid-2026.
NCI’s FY2026 budget was proposed for a 37-43% cut; Congress instead raised NIH overall slightly, but cancer grants are still funded below recommended levels.
A New York court reversed a student’s expulsion over a Turnitin false positive, and universities are switching AI-writing detectors off. The 2026 landscape.
NIH terminated its Minority Biomedical Research Support Program and froze diversity supplements in 2025 – what was cut, and where litigation stands now.
Congress rejected Trump’s proposed 40% NIH cut in FY2026, funding NIH at $48.7B — but grant terminations and indirect-cost fights still reshaped awards.
Where CASRAI is headed in 2027: priorities for the Dictionary, the federation work, CRediT v3 discussions, and the integration roadmap.
Suspect-paper triage at scale needs structured signal escalation. A practical model for moving manuscripts from orange-flag screening to red-flag investigation.
Five major journals’ GenAI disclosure wordings, side by side. What each requires, where they differ, and the practical implications for authors.
Institutional CRediT capture has a fixed-cost-versus-recurring-cost crossover. A practical model of where the tipping point lies and how to reach it faster.
The integrity community’s debate on how to engage with paper mills: confrontation, infiltration, or harm reduction. A look at what is actually working.
A 2026 audit of how the top-100 cited journals collect CRediT at submission. Coverage is up, but qualifier capture and JATS fidelity remain uneven.
A preview of the v2026.3 CASRAI Dictionary release: scope, new terms, deprecations, and the schema-evolution work threading through the update.
Reproducibility checklists at submission have proliferated. A walkthrough of the major ones, what they catch, and what authors should do to satisfy them efficiently.
A practical four-week implementation plan for a library-run CRediT helpdesk, with staffing, materials, workflows, and the first-month playbook.
NSF Notice 149 makes research-security training, MFTRP, and Confucius Institute certifications mandatory for proposals, effective Dec. 2, 2025.
ACM is creating its first director of research integrity role to clear a case backlog, joining Springer Nature and Elsevier in treating misconduct investigation as a dedicated, professionalized function rather than a volunteer committee job.
NIH’s April 2026 notice NOT-OD-26-072 reinstates the $25,000 subaward cap and 10% de minimis rate, rescinding 2025 flexibilities — a separate action from the litigated 15% cost cap.
ORCID iDs are now required by most major funders for PIs and increasingly for co-investigators. A practical map of where the requirements bite in 2026.
Software citation in 2026 runs on a three-cornered stack. The roles of DataCite, GitHub, and Zenodo — and what integrators should do about the seams.
Open peer review is mainstreaming. The signals, identifiers, and attribution mechanisms that make it work — and the gaps that still need closing in 2026.
RAiD has moved from pilot to operational service in several jurisdictions. A status report on adoption, integration patterns, and the questions still open.
Should mentorship be a CRediT role? The case for, the case against, and a proposed mid-path that recognises mentorship without breaking the taxonomy.
CRIS systems are converging on interoperability but the three dominant data models still misalign. A practical guide to the CERIF-Pure-VIVO triangle.
The CASRAI website has moved to a modern headless stack — Next.js front, WordPress back, federated with NISO, euroCRIS, CODATA, RDA, ORCID, Crossref, DataCite and ARDC.
The first stable release of the modernised CASRAI Dictionary ships today: 714 entries across 20 domains, CC-BY 4.0, machine-readable in seven formats.
When AI generated parts of a paper, which CRediT roles apply to the humans who prompted and verified? A working line between disclosure and contribution.
When a paper’s main output is code, the CRediT Software role bears the load. A practical guide to assigning Software for code-only research outputs.
Carbon-aware scheduling, geographic shifting, and the practical work of cutting academic HPC’s emissions footprint. What clusters are doing in 2026.
Eighteen months after NSPM-33 disclosure requirements took effect, a status report on what worked, what is broken, and the institutional adjustments still pending.
Latin America’s Diamond OA infrastructures have run a successful model for two decades. What the rest of the world is finally learning from SciELO, Latindex, and AmeliCA.
FAIR maximises openness; CARE centres Indigenous sovereignty. A walkthrough of the GIDA Manifesto’s reconciliation framework and what implementers should do.
ICMJE authorship plus CRediT contributorship: a practical 2026 guide to the 14 roles, lead/equal/supporting qualifiers, JATS XML, and journal-specific expectations.
NSF’s revised broader-impacts criterion sharpens evidence requirements. A practical guide for applicants and research administrators handling proposals in 2026.
ICMJE rejects AI as an author; publishers require structured disclosure. A 2026 map of who asks for what, the hallucination problem, RAG, and watermark detection.
The PID quartet that anchors modern research metadata: how ORCID, ROR, RAiD, and DOIs interlock in 2026, and what’s still broken at the crosswalk layer.
RDA’s DMP Common Standard v2 reorganises the machine-actionable data management plan. A field-by-field walkthrough of what changed and why.
Plan S compliance, Diamond OA’s rise, S2O models, Read-and-Publish agreements, and the slow rebalancing of who pays for global scholarly publishing.
UKRI’s Resume for Research and Innovation has matured. Why other funders should adopt narrative-CV formats, and the practical lessons from five years of UKRI experience.
A practitioner’s tour of EQUATOR’s reporting guidelines, when each applies, FAIR4RS for software, and the registered-report turn in 2026.
The 2026 EOSC Federation governance refresh: new node-membership criteria, the sustainability funding model, and how integrators should reposition.
From DORA (2012) to CoARA (2022) to UKRI’s 2024 R4RI mandate: the slow institutional turn against the impact factor and toward narrative CVs.
What the EU AI Act actually requires of research administrators, where the exemptions sit, and the practical compliance checklist for institutions in 2026.
From PDF DMP to RDA-compliant maDMP: tooling, integration, and the new requirement for software-management plans alongside data plans.
Role inflation, byline-order confusion, and missing writing roles: the three recurring CRediT failures editors flag, with concrete examples and fixes.
RDA Maturity Model, F-UJI, FAIR-Aware, CESSDA, ARDC: which FAIR assessment tool to choose, when, and how to integrate with institutional repositories.
PRISMA’s 2026 revision adds AI-assisted screening, living review checklists, and machine-readable flow diagrams. What systematic reviewers need to update.
Data papers and software papers don’t map cleanly onto the 14 CRediT roles. A practical guide to the friction and where the taxonomy needs work.
Cabanac’s Problematic Paper Screener, retraction wave, citation cartels, COPE flowcharts, and the United2Act initiative: where the publishing-integrity fight stands.
LEAF awards, My Green Lab certification, freezer management, single-use plastics, sustainable HPC, conference travel: practical sustainability in the 2026 research lab.
The case for a 15th CRediT role covering AI assistance, the counter-arguments, and a draft scope statement for the CASRAI community to test.
Current and pending support, foreign-component disclosure, NIH Other Support, foreign-talent-recruitment programmes: the 2026 NSPM-33 compliance landscape.
Crossref Grants, the Funder Registry, and the long-awaited grant-to-output linkage. What CRediT integrators need to know to consume the new graph.
The CARE Principles, OCAP, Te Mana Raraunga, Maiam nayri Wingara, FPIC, and Traditional Knowledge Labels: integrating Indigenous data sovereignty alongside FAIR.
ORCID’s 4.0 IDR refresh tightens the contributor-affiliation-funding crosswalk. A walkthrough of what changes for CASRAI integrations and what publishers should do now.
